Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
- PMID: 12844134
- DOI: 10.1016/S0009-9236(03)00068-7
Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
Abstract
Objectives: Marked interpatient variability exists in blood pressure response to beta-blocker monotherapy. We tested the hypothesis that 2 common polymorphisms in the gene for beta(1)-adrenergic receptor are associated with antihypertensive response to metoprolol in patients with uncomplicated hypertension.
Methods: Forty hypertensive men and women aged 35 to 65 years were studied. Baseline studies included 24-hour ambulatory blood pressure monitoring. Patients took 50 mg metoprolol twice daily with weekly titration to response or 200 mg twice daily. After a minimum of 4 weeks at stable dose, treatment phase 24-hour ambulatory blood pressure monitoring was repeated. The codon 49 and 389 genotypes for beta(1)-adrenergic receptor were determined by polymerase chain reaction with restriction fragment length polymorphism. Multilinear regression was performed to determine the impact of genotype and other variables on blood pressure response to metoprolol.
Results: Patients homozygous for Arg at codon 389 had a nearly 3-fold greater reduction in daytime diastolic blood pressure (-13.3% +/- 8.4% versus -4.5% +/- 8.2%, P =.0018) compared with those who carried the variant allele. The haplotype pair (diplotype) for beta(1)-adrenergic receptor was also a significant predictor of response, with patients having the Ser49Arg389/Ser49Arg389 diplotype demonstrating a decline in blood pressure of 14.7 mm Hg versus 0.5 mm Hg in patients with the Gly49Arg389/Ser49Gly389 diplotype. In multiregression analysis, baseline daytime diastolic blood pressure, codon 389 genotype, and codon 49 genotype were significant predictors of blood pressure after treatment.
Conclusions: Our data suggest that beta(1)-adrenergic receptor polymorphisms are important determinants of antihypertensive response to metoprolol. In the future, codon 49 and 389 genotypes or beta(1)-adrenergic receptor haplotypes might be used to predict the diastolic blood pressure response to metoprolol in patients with hypertension.
Comment in
-
The Gly389Arg beta1-adrenergic receptor polymorphism: a predictor of response to beta-blocker treatment?Clin Pharmacol Ther. 2003 Oct;74(4):299-302. doi: 10.1016/S0009-9236(03)00223-6. Clin Pharmacol Ther. 2003. PMID: 14534516 Review. No abstract available.
Similar articles
-
beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.Clin Pharmacol Ther. 2006 Jul;80(1):23-32. doi: 10.1016/j.clpt.2006.03.004. Epub 2006 Jun 8. Clin Pharmacol Ther. 2006. PMID: 16815314 Clinical Trial.
-
Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.Clin Pharmacol Ther. 2003 Oct;74(4):372-9. doi: 10.1016/S0009-9236(03)00224-8. Clin Pharmacol Ther. 2003. PMID: 14534524 Clinical Trial.
-
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.Clin Pharmacol Ther. 2004 Dec;76(6):536-44. doi: 10.1016/j.clpt.2004.08.020. Clin Pharmacol Ther. 2004. PMID: 15592325
-
beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese.Ann Hum Genet. 2005 Jan;69(Pt 1):36-44. doi: 10.1046/j.1529-8817.2003.00093.x. Ann Hum Genet. 2005. PMID: 15638826 Review.
-
Variability in beta-adrenergic receptor response in the vasculature: Role of receptor polymorphism.J Allergy Clin Immunol. 2002 Dec;110(6 Suppl):S318-21. doi: 10.1067/mai.2002.129701. J Allergy Clin Immunol. 2002. PMID: 12464942 Review.
Cited by
-
Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.Genes (Basel). 2024 Mar 20;15(3):379. doi: 10.3390/genes15030379. Genes (Basel). 2024. PMID: 38540438 Free PMC article. Review.
-
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability.Clin Auton Res. 2024 Feb;34(1):205-208. doi: 10.1007/s10286-023-01001-4. Epub 2023 Nov 30. Clin Auton Res. 2024. PMID: 38032435 No abstract available.
-
β1-adrenergic receptor polymorphisms: a possible genetic predictor of bisoprolol response in acute coronary syndrome.Future Sci OA. 2023 Aug 22;9(10):FSO895. doi: 10.2144/fsoa-2023-0113. eCollection 2023 Dec. Future Sci OA. 2023. PMID: 37753361 Free PMC article.
-
Role of G-protein coupled receptors in cardiovascular diseases.Front Cardiovasc Med. 2023 Jun 5;10:1130312. doi: 10.3389/fcvm.2023.1130312. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37342437 Free PMC article. Review.
-
Is it time for genetic modifiers to predict prognosis in Duchenne muscular dystrophy?Nat Rev Neurol. 2023 Jul;19(7):410-423. doi: 10.1038/s41582-023-00823-0. Epub 2023 Jun 12. Nat Rev Neurol. 2023. PMID: 37308617 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases